This study aimed to systematically identify Cpn’s therapeutic targets and pathways in Western diet (WD)-induced obesity using integrated network pharmacology, transcriptomics, and experimental validation. The gene discussed is CPN1; the disease is obesity due to melanocortin 4 receptor deficiency.